Lv4
480 积分 2024-05-02 加入
Qualification of impurities based on metabolite data
15天前
已完结
New limits proposed for the management of non-mutagenic impurities
15天前
已完结
Critical Assessment of Pharmaceutical ProcessesA Rationale for Changing the Synthetic Route
26天前
已完结
Industry Perspective on the Selection of Regulatory Starting Materials for Synthetic Peptides
26天前
已完结
Quality Control for Incoming Raw Materials Beyond Identity and Purity: Case Studies from Recent Merck API Manufacturing Processes
26天前
已完结
Predictive Methodology for Selecting the “Fit-for-Purpose” LC-HRMS Method for Quality Assessment in Peptide Synthesis
26天前
已完结
Enabling Data-Driven Solubility Modeling at GSK: Enhancing Purge Predictions for Mutagenic Impurities
26天前
已完结
The Eight Criteria Defining a Good Chemical Manufacturing Process
26天前
已完结
Using Quality by Design Principles in Setting a Control Strategy for Product Quality Attributes
26天前
已完结
Quality by Design in Action 2: Controlling Critical Material Attributes during the Synthesis of an Active Pharmaceutical Ingredient
26天前
已完结
皖公网安备34019202002308
